Related Experiment Video
Updated: Jun 14, 2026
07:46
In Vitro Differentiation of Naive CD4+ T Cells into Pathogenic Th17 Cells in Mouse
Published on: October 25, 2024
Th17 cells: positive or negative role in tumor?
1Department of Clinical Hematology, Second Hospital of Xi'an Jiaotong University, Xi'an, China.
Cancer Immunology, Immunotherapy : CII
|March 31, 2010
Summary
T helper 17 (Th17) cells
Area of Science:
- Immunology
- Oncology
Background:
- T helper 17 (Th17) cells are a distinct T helper cell lineage.
- Their presence in cancer models and human cancers is established.
- Their precise role in tumor progression and anti-tumor immunity is debated.
Purpose of the Study:
- To review the current literature on IL-17/IL-23 and Th17 cells in cancer.
- To discuss the potential roles of Th17 cells in cancer development.
- To identify research gaps for developing targeted therapies.
Main Methods:
- Literature review of existing studies on Th17 cells and cancer.
- Analysis of the interleukin-17 (IL-17) and interleukin-23 (IL-23) signaling pathways in cancer.
- Synthesis of findings to evaluate the controversial roles of Th17 cells.
Main Results:
- Th17 cells and their associated cytokines (IL-17/IL-23) are found in various cancer types.
- Evidence suggests Th17 cells may both promote and inhibit tumor growth.
- The exact function of Th17 cells in cancer is context-dependent and not fully understood.
Conclusions:
- The role of Th17 cells in cancer remains controversial, with evidence supporting both pro-tumor and anti-tumor functions.
- Further research is needed to clarify the complex interactions between Th17 cells, cytokines, and the tumor microenvironment.
- Resolving these issues is crucial for designing effective immunotherapies targeting Th17 cells in cancer treatment.
Related Concept Videos
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:22T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...